Search

everythinglearnresearchcommunity

for

Search:↓

Various treatments for common hair loss in men and women are effective, but should be tailored to individual needs and potential side effects.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Androgenetic alopecia is more common in Saudi men than women.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

New understanding and treatments for hair loss are improving, but more research is needed.

More personalized and effective treatments for androgenetic alopecia are needed.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

IGF-1R may play a role in female hair loss and could be a treatment target.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Shampoos clean and improve hair, boosting confidence and quality of life.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

PRP injections increase hair density and diameter in female androgenetic alopecia patients.

Scalp microneedling may improve hair density and thickness for various alopecia types.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.